- Home
- CUK vs TEVA Comparison
CUK vs TEVA Comparison
Compare CUK & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUK
- TEVA
- Stock Information
- Founded
- CUK 1972
- TEVA 1901
- Country
- CUK United States
- TEVA Israel
- Employees
- CUK N/A
- TEVA N/A
- Industry
- CUK Marine Transportation
- TEVA Biotechnology: Pharmaceutical Preparations
- Sector
- CUK Consumer Discretionary
- TEVA Health Care
- Exchange
- CUK Nasdaq
- TEVA Nasdaq
- Market Cap
- CUK 29.6B
- TEVA 23.7B
- IPO Year
- CUK 2000
- TEVA N/A
- Fundamental
- Price
- CUK $23.21
- TEVA $21.83
- Analyst Decision
- CUK Buy
- TEVA Buy
- Analyst Count
- CUK 18
- TEVA 7
- Target Price
- CUK $26.72
- TEVA $22.43
- AVG Volume (30 Days)
- CUK 1.4M
- TEVA 8.9M
- Earning Date
- CUK 12-20-2024
- TEVA 01-29-2025
- Dividend Yield
- CUK N/A
- TEVA N/A
- EPS Growth
- CUK N/A
- TEVA N/A
- EPS
- CUK 1.44
- TEVA N/A
- Revenue
- CUK $25,021,000,000.00
- TEVA $16,772,000,000.00
- Revenue This Year
- CUK $7.75
- TEVA $5.74
- Revenue Next Year
- CUK $3.60
- TEVA $4.46
- P/E Ratio
- CUK $17.47
- TEVA N/A
- Revenue Growth
- CUK 15.88
- TEVA 9.81
- 52 Week Low
- CUK $12.50
- TEVA $11.48
- 52 Week High
- CUK $24.66
- TEVA $22.80
- Technical
- Relative Strength Index (RSI)
- CUK 57.03
- TEVA 60.46
- Support Level
- CUK $22.26
- TEVA $21.21
- Resistance Level
- CUK $22.85
- TEVA $22.10
- Average True Range (ATR)
- CUK 0.72
- TEVA 0.62
- MACD
- CUK 0.09
- TEVA -0.11
- Stochastic Oscillator
- CUK 68.59
- TEVA 69.42
About CUK Carnival Plc ADS ADS
Carnival is the largest global cruise company, with more than 90 ships in service at the end of fiscal 2024. Its portfolio of brands includes Carnival Cruise Lines, Holland America, Princess Cruises, and Seabourn in North America; P&O Cruises and Cunard Line in the United Kingdom; Aida in Germany; Costa Cruises in Southern Europe. It's currently folding its P&O Australia brand into Carnival. The firm also owns Holland America Princess Alaska Tours in Alaska and the Canadian Yukon. Carnival's brands attracted 14 million guests in 2024.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.